Otsuka Holdings Co., Ltd. (OTSKF)
77.53
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Otsuka Holdings EPS Diluted (Quarterly) : 1.398 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.398 |
| March 31, 2026 | 1.188 |
| December 31, 2025 | 0.8049 |
| September 30, 2025 | 1.594 |
| June 30, 2025 | 1.159 |
| March 31, 2025 | 1.040 |
| December 31, 2024 | 1.847 |
| September 30, 2024 | 1.037 |
| June 30, 2024 | 0.3596 |
| March 31, 2024 | 0.9604 |
| December 31, 2023 | -0.4996 |
| September 30, 2023 | 0.7536 |
| June 30, 2023 | 0.5515 |
| March 31, 2023 | 0.8549 |
| December 31, 2022 | 0.2979 |
| September 30, 2022 | 0.5497 |
| June 30, 2022 | 0.6613 |
| March 31, 2022 | 0.3672 |
| December 31, 2021 | -0.0192 |
| September 30, 2021 | 0.5887 |
| June 30, 2021 | 0.7797 |
| March 31, 2021 | 0.7693 |
| December 31, 2020 | 0.3595 |
| September 30, 2020 | 0.7039 |
| June 30, 2020 | 0.8279 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6236 |
| December 31, 2019 | 0.2652 |
| September 30, 2019 | 0.72 |
| June 30, 2019 | 0.8023 |
| March 31, 2019 | 0.3076 |
| December 31, 2018 | 0.0718 |
| September 30, 2018 | 0.2195 |
| June 30, 2018 | 0.6962 |
| March 31, 2018 | 0.3808 |
| December 31, 2017 | 0.6445 |
| September 30, 2017 | 0.5042 |
| June 30, 2017 | 0.3533 |
| March 31, 2017 | 0.3393 |
| December 31, 2016 | -0.254 |
| September 30, 2016 | 1.045 |
| June 30, 2016 | 0.474 |
| March 31, 2016 | 0.3503 |
| December 31, 2015 | -0.2899 |
| September 30, 2015 | 0.5084 |
| June 30, 2015 | 0.5397 |
| March 31, 2015 | 0.5259 |
| December 31, 2014 | 0.7032 |
| September 30, 2014 | 0.9634 |
| June 30, 2014 | 0.8131 |
| March 31, 2014 | 0.8991 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Eisai Co., Ltd. | 0.1015 |
| Chugai Pharmaceutical Co., Ltd. | 0.2218 |
| Santen Pharmaceutical Co., Ltd. | 0.1399 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 748.32M |
| Revenue (Quarterly) | 4.406B |
| Total Expenses (Quarterly) | 3.670B |
| Enterprise Value | 39.45B |
| Gross Profit Margin (Quarterly) | 72.68% |
| Profit Margin (Quarterly) | 16.99% |
| Earnings Yield | 6.43% |
| Operating Earnings Yield | 7.15% |
| Normalized Earnings Yield | 6.767 |